Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Number of holders
-
932
-
Total 13F shares, excl. options
-
128,518,741
-
Shares change
-
+594,963
-
Total reported value, excl. options
-
$27,691,040,526
-
Value change
-
+$55,007,555
-
Put/Call ratio
-
101%
-
Number of buys
-
380
-
Number of sells
-
496
-
Price
-
$215.63
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q1 2024
As of 31 Mar 2024 BIOGEN INC. - COM (BIIB) had 932 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 128,518,741 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., STATE STREET CORP, T. Rowe Price Investment Management, Inc., WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, VAN ECK ASSOCIATES CORP, and MORGAN STANLEY.
This table shows 933 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.